NCT01004003 2017-10-26Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular CarcinomaBoehringer IngelheimPhase 2 Completed125 enrolled 19 charts
NCT00987935 2016-03-10A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma PatientsBoehringer IngelheimPhase 2 Completed134 enrolled 29 charts
NCT01594125 2016-02-12Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular CarcinomaBoehringer IngelheimPhase 1 Completed30 enrolled 12 charts